Imaging and Staging of Esophageal Malignancy
- Multimodal approach to therapy demonstrates survival benefits, employing neoadjuvant chemotherapy, radiation therapy, or both, followed by surgical resection.
- EUSG vs. PET/MRI - PET/MRI demonstrates slightly superior accuracy for staging of lymph nodes, and may provide an important role in preoperative esophageal cancer in the future.
- Evidence that 18F-FDG PET/CT is the best systemic staging modality in esophageal cancer. Although expensive, and thus not the initial approach for diagnosis, PET/CT allows for optimization of relationship of anatomic abnormalities and hypermetabolic areas. The degree of hypermetabolism has also shown utility in prognosis. Furthermore, some argue that repeat PET/CT after neoadjuvant therapy should be performed to detect metastatic disease previously not appreciated.